Latest Exclusive Distribution Agreements News

Stealth Group Holdings has reported a record-breaking 2025 financial year, with sales climbing 27.6% and net profit more than doubling. The company is accelerating its growth strategy, aiming to more than double sales by 2028.

Shaver Shop Group Limited reported a slight dip in FY25 sales but achieved record gross margins and EBIT growth, driven by its successful Transform-U private brand launch. Early FY26 trading shows promising sales momentum.

Shaver Shop Group reported a slight dip in FY25 sales but achieved record gross margins and EBIT growth, driven by its new private label and exclusive brand deals.

MaxiPARTS Limited reported a robust FY25 with revenues climbing 9.5% to $267.1 million and net profit soaring 179% to $7.7 million, underpinned by strategic acquisitions and margin improvements.

SportsHero Limited has entered the Southeast Asian mobile gaming market by signing an exclusive distribution agreement with Yes2Games, bringing globally popular titles like Fruit Ninja and Jetpack Joyride to Indonesia, the Philippines, Thailand, and Malaysia.

Aumake Limited reported a remarkable 213% surge in quarterly cash receipts, driven by exclusive distribution agreements and strategic cost reductions, setting the stage for profitability in FY26.

OncoSil Medical has reported a record 20% quarterly increase in dose sales and secured $8.7 million in new capital, underpinning its clinical and commercial expansion in pancreatic cancer treatment.

Osteopore Limited reports a three-fold increase in craniofacial implant sales within a year of signing an exclusive distribution deal with Zimmer Biomet, signaling strong early traction across key global markets.

Wide Open Agriculture reports a remarkable 243% jump in cash receipts driven by soaring lupin protein sales and secures a strategic foothold in China through an exclusive distribution deal.

RLF AgTech Ltd has closed FY2025 with a remarkable 74% increase in customer receipts and positive operating cash flow, underpinned by a comprehensive restructuring and renewed market momentum across Australia, China, and Asia.

Lumos Diagnostics has inked a landmark six-year exclusive distribution agreement with PHASE Scientific for its FebriDx® rapid diagnostic test in the US, potentially unlocking nearly half a billion Australian dollars in revenue contingent on FDA approval.

Osteopore Limited has gained Swiss market approval for its 3D-printed bioresorbable implants under the EU Medical Device Regulation, completing its European product portfolio and strengthening its partnership with Zimmer Biomet.